Cargando…
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
The standard regimens for graft-versus-host disease (GvHD) prophylaxis in matched unrelated donor (MUD) transplantation were based on antithymocyte globulin (ATG) in combination with calcineurin inhibitors (CNIs). To improve the efficiency of GvHD prophylaxis in MUD peripheral blood stem cell transp...
Autores principales: | Sun, Xi, Yang, Jun, Cai, Yu, Wan, Liping, Huang, Chongmei, Qiu, Huiying, Tong, Yin, Xu, Xiaowei, Zhou, Kun, Ding, Xueying, Song, Xianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486671/ https://www.ncbi.nlm.nih.gov/pubmed/34035462 http://dx.doi.org/10.1038/s41409-021-01358-y |
Ejemplares similares
-
Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
por: Xu, Xiaoqian, et al.
Publicado: (2020) -
Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant
Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft
Versus Host Disease After Haploidentical Peripheral Blood
Stem Cell Transplantation With Maternal/Collateral Related
Donors
por: Li, Ting, et al.
Publicado: (2022) -
Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021) -
Antithymocyte-globulin/mycophenolate-mophetil: Lymphopenia: 3 case reports
Publicado: (2021) -
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
por: Yang, Jun, et al.
Publicado: (2018)